Back
Top 0.2%
11.7%
Top 5%
11.7%
Top 53%
11.7%
Top 1%
7.7%
Top 1%
5.9%
Top 29%
5.9%
Top 0.4%
5.9%
Top 3%
5.0%
Top 2%
4.1%
Top 6%
3.8%
Top 10%
3.8%
Top 16%
1.9%
Top 43%
1.5%
Top 5%
1.5%
Top 3%
1.5%
Top 11%
1.3%
Top 35%
1.3%
Top 0.5%
1.2%
Top 14%
0.9%
Top 4%
0.9%
Top 95%
0.7%
Taking injectable PrEP to scale: Optimising the value of lenacapavir for South Africa's HIV response
2025-12-15
health economics
Title + abstract only
View on medRxiv
Show abstract
BackgroundSouth Africa accounts for 20% of the global HIV infections and has one of the highest HIV incidence rates in the world. Six-monthly injectable lenacapavir (LEN) for HIV pre-exposure prophylaxis (PrEP) has superior efficacy to oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC), and similar efficacy to 2-monthly injectable cabotegravir (CAB). With LENs recent regulatory approval and the newly negotiated generic price of $40 per person per year, South Africa faces critical impleme...
Predicted journal destinations
1
Journal of the International AIDS Society
19 training papers
2
PLOS Global Public Health
287 training papers
3
PLOS ONE
1737 training papers
4
BMJ Global Health
95 training papers
5
AIDS
25 training papers
6
BMJ Open
553 training papers
7
PLOS Medicine
95 training papers
8
BMC Medicine
155 training papers
9
Proceedings of the National Academy of Sciences
100 training papers
10
PLOS Neglected Tropical Diseases
166 training papers
11
Clinical Infectious Diseases
219 training papers
12
BMC Public Health
148 training papers
13
Nature Communications
483 training papers
14
Vaccine
140 training papers
15
BMC Health Services Research
43 training papers
16
The Journal of Infectious Diseases
137 training papers
17
eLife
262 training papers
18
The Lancet Global Health
24 training papers
19
Open Forum Infectious Diseases
124 training papers
20
eClinicalMedicine
55 training papers
21
Scientific Reports
701 training papers